PHARMACEUTICAL INGREDIENTS FUNDAMENTALS EXPLAINED

“The existing situation has exposed some structural weaknesses in the EU’s medicines source chain and a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides claimed. She advised that provide chain concerns be dealt with in an EU pharmaceutical technique predicted to generally be introduced by